We found that CSA only accounted for a fraction of CDO1-dependent (CYS)2 depletion (Figure 4—figure supplement 1B), suggesting that CSA is metabolized to an alternative product in NSCLC cell lines. This evidence concerns the gene CDO1 and non-small cell lung carcinoma.